Sernova Stock Price, News & Analysis (CVE:SVA)

C$0.41 0.00 (0.00 %)
(As of 01/16/2018 08:41 AM ET)
Previous CloseC$0.41
Today's RangeC$0.40 - C$0.45
52-Week RangeC$0.15 - C$0.51
Volume242,000 shs
Average Volume311,277 shs
Market CapitalizationC$65.37 million
P/E Ratio-41.00
Dividend YieldN/A
Beta-0.02

About Sernova (CVE:SVA)

Sernova Corp. is a development-stage regenerative medicine company. The Company is engaged in the development of its Cell Pouch and associated technologies, including therapeutic cells for the treatment of chronic diseases and local immune protection technologies. It is focused on developing a treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted and prevascularized medical device (the Cell Pouch), protected from immune system attack. The Cell Pouch is designed to create a microvessel rich, tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the treatment of chronic diseases, such as diabetes and thyroid disease. Its lead program is the clinical development of the Cell Pouch for treatment of patients with insulin dependent diabetes. It is also evaluating Cell Pouch for the treatment of patients with hemophilia A.

Receive SVA News and Ratings via Email

Sign-up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorHealthcare
SymbolCVE:SVA
CUSIPN/A
Phone+1-519-8585184

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-41
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($0.01)
Net IncomeN/A
Net MarginsN/A
Return on Equity-58.97%
Return on Assets-49.67%

Miscellaneous

EmployeesN/A
Outstanding Shares159,374,000

Sernova (CVE:SVA) Frequently Asked Questions

What is Sernova's stock symbol?

Sernova trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVA."

When will Sernova make its next earnings announcement?

Sernova is scheduled to release their next quarterly earnings announcement on Monday, February, 5th 2018. View Earnings Estimates for Sernova.

Who are some of Sernova's key competitors?

Who are Sernova's key executives?

Sernova's management team includes the folowing people:

  • Frank A. Holler, Chairman of the Board (Age 57)
  • Philip Toleikis, President, Chief Executive Officer
  • Scott Langille, Chief Financial Officer (Age 59)
  • James T. Parsons, Director
  • Bruce Weber, Director
  • Jeffrey A. Bacha, Independent Director (Age 48)

How do I buy Sernova stock?

Shares of Sernova and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Sernova's stock price today?

One share of Sernova stock can currently be purchased for approximately C$0.41.

How big of a company is Sernova?

Sernova has a market capitalization of C$65.37 million.

How can I contact Sernova?

Sernova's mailing address is 700 Collip Cir Suite 114, LONDON, ON N6G 4X8, Canada. The company can be reached via phone at +1-519-8585184.


MarketBeat Community Rating for Sernova (SVA)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  17
MarketBeat's community ratings are surveys of what our community members think about Sernova and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Sernova (CVE:SVA) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Sernova (CVE:SVA) Earnings History and Estimates Chart

Earnings by Quarter for Sernova (CVE:SVA)

Sernova (CVE SVA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2018        
9/30/2016Q3 2016C($0.01)ViewN/AView Earnings Details
1/18/2016Q4 2015C($0.01)ViewN/AView Earnings Details
6/29/2015Q2 2015C($0.01)ViewN/AView Earnings Details
2/27/2015Q4 2014C($0.01)ViewN/AView Earnings Details
9/30/2014Q3 2014C($0.01)ViewN/AView Earnings Details
6/30/2014Q2 2014C($0.01)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Sernova (CVE:SVA) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sernova (CVE:SVA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sernova (CVE SVA)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Sernova (CVE SVA) News Headlines

Source:
DateHeadline
IIROC Trading Halt - SVAIIROC Trading Halt - SVA
www.bizjournals.com - December 8 at 5:43 PM

SEC Filings

Sernova (CVE:SVA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Sernova (CVE SVA) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.